Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
about
Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@en
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@nl
type
label
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@en
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@nl
prefLabel
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@en
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@nl
P2860
P50
P1476
Cardiac fibrosis can be attenu ...... tive small-molecule inhibitor.
@en
P2093
Gregory Y H Lip
Martin Griffin
P2860
P2888
P356
10.1038/S41419-018-0573-2
P577
2018-04-27T00:00:00Z
P6179
1104089461